Dear Member,

HealthShare NSW has informed the HSU of a proposed restructure within the Agency for Clinical Innovation. In February 2023, ACI transitioned to a chief executive-governed organisation and formed part of the newly established Clinical Innovation and Research Division.

The chief executive and deputy secretary (dual role) has nine direct reports across the division. The proposed restructure will reduce the chief executive and deputy secretary direct reports at ACI to 5.

The proposed restructure will cut three HSM6 roles and see the implementation of eight new roles across HSM2, HSM4 and HSM5 grades.

You can view the correspondence at the below links:

• ACI – HSU Letter
• ACI – Current and Proposed structure

What do you think?

It is important for union members to lead this discussion. How will this affect you?

Please send your feedback to [E-Mail not displayed] by COB 2 September 2024 using the subject HealthShare NSW Agency for Clinical Innovation Restructure.

Your union at work

Everyone affected by these changes needs to be a union member. Members deserve to have control over their working lives. Tell your colleagues now is the time to join.

Do you know someone who isn’t an HSU member? Encourage them to join our Union today and have a say at work. We are always stronger when we stand together.

New members can join at www.hsu.asn.au/join or call 1300 478 679.